Skip to main content
    R

    Revvity Inc. (RVTY)

    Official site

    HEALTHCARE • DIAGNOSTICS & RESEARCH • NYSE

    $148.87
    -5.52 (-3.58%)

    Market Cap: $17.24B

    Last updated: Nov 17, 2026 at 11:05 AM ET

    Revvity Inc. (RVTY) Competitors

    Updated Nov 17, 2026. Similar companies are ranked by business profile, size, sector and industry; metrics come from company filings and market prices.

    The companies most similar to Revvity are Charles River Laboratories (CRL), Quest Diagnostics (DGX) and Medpace Holdings (MEDP). Revvity trades at 26.8x earnings, against a median of 31.8x for the 11 of these companies with a P/E. By market cap, Revvity ranks 9th of the 13 companies on this page; IDEXX Laboratories (IDXX) is the largest at $55.48B.

    Peer Comparison

    RVTY's ROIC of 3.4% is below the peer median of 8.2%, and its revenue growth of 4.3% is below the median of 7.5%. It yields 0.19%, while the median peer pays no dividend.

    CompanyMarket capP/EP/SNet marginROICRev growthDiv yield
    Revvity (RVTY)$17.24B26.8x5.6x8.6%3.4%4.3%0.19%
    Charles River Laboratories (CRL)$16.19B31.8x4.0x1.0%0.1%-2.2%0.00%
    Quest Diagnostics Incorporated (DGX)$28.56B23.8x2.4x9.5%10.2%10.0%1.31%
    Medpace Holdings Inc (MEDP)$18.29B35.9x6.4x18.2%N/A8.5%0.00%
    IQVIA Holdings Inc (IQV)$43.69B22.0x2.5x8.1%8.5%8.0%0.00%
    ICON PLC (ICLR)$14.58B20.0x1.8x5.3%2.8%-2.9%0.00%
    Labcorp Holdings Inc. (LH)$30.08B20.6x2.1x6.9%8.2%6.9%0.77%
    Illumina Inc (ILMN)$31.30B37.7x6.6x19.7%19.1%4.2%0.00%
    Qiagen NV (QGEN)$10.30B20.5x4.9x18.2%8.2%2.9%0.70%
    Natera Inc (NTRA)$46.27BN/A14.3x-5.7%-8.5%34.1%0.00%
    IDEXX Laboratories Inc (IDXX)$55.48B47.3x11.8x25.4%44.3%9.9%0.00%
    Mettler-Toledo International Inc (MTD)$34.59B37.3x8.2x22.3%47.1%6.3%0.00%
    RadNet Inc (RDNT)$6.02B141.5x2.5x-0.9%2.7%22.1%0.00%
    Peer median$29.32B31.8x4.5x8.8%8.2%7.5%0.00%
    Market data as of Nov 17, 2026. Net margin covers the trailing 12 months, Rev growth compares the latest quarter with a year earlier and Div yield is the forward yield. P/E uses earnings per share for the last 12 months as companies report it, often adjusted, so it can show beside a negative net margin, which uses net income. P/E and P/S show N/A when those earnings or sales are negative or missing, or the multiple is above 1,000x.

    Similar Companies

    These are the 12 companies most similar to Revvity, ranked by how closely their business, size, sector and industry match. All 12 are in one industry, Diagnostics & Research.

    CompanyAboutPeers
    Charles River Laboratories (CRL)
    Charles River Laboratories International, Inc., is an American pharmaceutical company specializing in a variety of preclinical and clinical laboratory...
    CRL competitors
    Quest Diagnostics Incorporated (DGX)
    Quest Diagnostics is an American clinical laboratory. A Fortune 500 company, Quest operates in the United States, Puerto Rico, Mexico, and Brazil.
    DGX competitors
    Medpace Holdings Inc (MEDP)
    Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia.
    MEDP competitors
    IQVIA Holdings Inc (IQV)
    IQVIA, formerly Quintiles and IMS Health, Inc., is an American multinational company serving the combined industries of health information technology...
    IQV competitors
    ICON PLC (ICLR)
    ICON Public Limited Company, a clinical research organization, provides outsourced marketing and development services in Ireland, the rest of Europe...
    ICLR competitors
    Labcorp Holdings Inc. (LH)
    Laboratory Corporation of America Holdings, more commonly known as Labcorp, is an American company headquartered in Burlington, North Carolina.
    LH competitors
    Illumina Inc (ILMN)
    Illumina, Inc. is an American company.
    ILMN competitors
    Qiagen NV (QGEN)
    QIAGEN NV provides sample-to-knowledge solutions that transform biological materials into molecular knowledge globally.
    QGEN competitors
    Natera Inc (NTRA)
    Natera, Inc., a diagnostic company, develops and markets molecular testing services globally. The company is headquartered in San Carlos, California.
    NTRA competitors
    IDEXX Laboratories Inc (IDXX)
    IDEXX Laboratories, Inc. is an American multinational corporation engaged in the development, manufacture...
    IDXX competitors
    Mettler-Toledo International Inc (MTD)
    Mettler Toledo (NYSE: MTD) is a multinational manufacturer of scales and analytical instruments.
    MTD competitors
    RadNet Inc (RDNT)
    RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.
    RDNT competitors

    Frequently Asked Questions About RVTY

    Who are Revvity's main competitors?

    The companies most similar to Revvity include Charles River Laboratories (CRL), Quest Diagnostics (DGX), Medpace Holdings (MEDP), IQVIA Holdings (IQV) and ICON (ICLR), listed from the closest match.

    Who is Revvity's biggest competitor?

    IDEXX Laboratories (IDXX) is the largest of the similar companies at $55.48B; Charles River Laboratories (CRL) is the closest match by business profile, size, sector and industry.

    How does RVTY stock compare with its competitors?

    RVTY's P/E is 26.8x against a peer median of 31.8x; its P/S is 5.6x against a peer median of 4.5x; its net margin is 8.6% against a peer median of 8.8%.

    Which of Revvity's competitors pays a higher dividend?

    Revvity has a forward dividend yield of 0.19%. Quest Diagnostics (DGX), Labcorp Holdings (LH) and Qiagen NV (QGEN) have higher forward dividend yields; Quest Diagnostics (DGX) has the highest at 1.31%.

    Is Revvity bigger than its competitors?

    No. Revvity is 9th by market cap among the 13 companies on this page; the largest is IDEXX Laboratories (IDXX) at $55.48B.